SI‑BONE (SIBN) CEO Laura Francis Sells Shares

What Happened
Laura Francis, CEO of SI‑BONE (SIBN), reported open‑market sales totaling 55,807 shares on Aug 20–21, 2026, generating roughly $1,088,201. The bulk was sold on 2026‑08‑20 (51,884 shares at a weighted‑average $19.46, proceeds $1,009,663) and a smaller block on 2026‑08‑21 (3,923 shares at a weighted‑average $20.02, proceeds $78,538). These transactions are sales (not purchases).

Key Details

• Dates/prices: 08/20/2026 — 51,884 shares @ weighted‑avg $19.46 (range $19.10–$19.73); 08/21/2026 — 3,923 shares @ weighted‑avg $20.02 (range $20.00–$20.05).
• Total sold: 55,807 shares for ~$1,088,201.
• Plan/authorization: Sales were effected pursuant to a 10b5‑1 trading plan dated May 21, 2026 (pre‑arranged trading plan).
• Holdings after trade: Filing notes holdings include shares held by The David & Laura Joint Rev Tr and 355,697 shares issuable on settlement of restricted stock units; the excerpt does not state an exact total beneficial ownership after the sales.
• Filing timeliness: Form 4 was filed the next day (08/21/2026) for transactions through 08/20–08/21, consistent with timely reporting requirements.

Context
A 10b5‑1 plan indicates these trades were executed under a pre‑arranged strategy, which is common for insiders to avoid trading on nonpublic information; this is a routine insider sale rather than an outright buy signal. The filing’s footnotes provide weighted‑average prices and ranges and note the presence of RSUs and trust‑held shares; additional per‑price breakdowns are available upon request to the issuer or the SEC staff.